Company Overview of Indel Therapeutics Inc
Indel Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics to address the global health crisis caused by antibiotic resistance. It also grows a pipeline of novel antibiotic drug discovery programs focused on curing difficult to treat and hospital acquired infections. Indel Therapeutics was founded in 2008 and is based in Vancouver, Canada.
4068 West 11th Avenue
Vancouver, BC V6R 2L3
Founded in 2008
Key Executives for Indel Therapeutics Inc
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Indel Therapeutics Inc, please visit www.indeltherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.